Nurses play an important role in providing vaccine information and supporting informed vaccination decisions.
This study will evaluate a digital educational intervention designed for registered nurses in Quebec. The intervention will provide education about vaccination, including immunology, epidemiology, vaccine communication, motivational interviewing, and responding to vaccine misinformation.
Registered nurses will be randomly assigned to either the intervention group or a control group. The study will examine whether the intervention improves vaccine confidence and vaccine communication compared with the control group.
Participants will complete questionnaires before and after the intervention, with follow-up assessments at 3 and 6 months. The study will assess vaccine hesitancy and changes in vaccine-related knowledge, communication skills, and vaccination recommendation practices.
The findings will help determine whether a digital educational intervention can support nurses in their vaccine-related communication and professional practice.
Registered nurse authorized to practice in Quebec.
Aged 18 years or older.
Able to provide informed consent.
Able to complete the study questionnaires in French or English and digital educational intervention in French.
Not currently authorized to practice as a registered nurse in Quebec.
Unable to provide informed consent.
Previous participation in the VaxNurse pilot study.
Parallel
Digital educational intervention
Other interventionThe VaxNurse digital educational intervention is designed for registered nurses. It includes educational content on immunology and epidemiology, motivational interviewing, vaccine communication, and strategies for responding to vaccine misinformation. The intervention aims to reduce vaccine hesitancy and strengthen knowledge related to vaccine, confidence, communication skills, and recommendation practices. It complements existing immunization training provided by the INSPQ.
the Vaccine Hesitancy Scale (VHS)
Vaccine hesitancy will be assessed using the Vaccine Hesitancy Scale (VHS). The total score ranges from 10 to 50, with higher scores indicating greater vaccine hesitancy. Change from baseline will be compared between the intervention and control groups across follow-up assessments.
Click on the lead sponsor to view all of their trials.
Universite du Quebec en Outaouais
Lead sponsor
Ministere de la Sante et des Services Sociaux
Collaborator
McGill University
Collaborator
Angers University
Collaborator
Université Victor Segalen Bordeaux 2
Collaborator
ordre des infirmières et des infirmiers du Québec
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
